During the past decade, Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf" are "Lung Cancer" (2 trials), "EGFR Exon 19 Deletion" (1 trials), "EGFR L858R" (1 trials), "Non-Small Cell Lung Cancer Metastatic" (1 trials) and "Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor" (1 trials). Many other conditions were trialed in "Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf" in a lesser frequency.

Most popular intervention types in "Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf" are "Drug" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cates plot" (1 trials), "Fact box" (1 trials), "Patritumab Deruxtecan" (1 trials), "Patritumab Deruxtecan (Fixed dose)" (1 trials) and "Patritumab Deruxtecan (Up-Titration)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Karl Landsteiner Institut für Lungenforschung und pneumologische Onkologie c/o Klinik Floridsdorf, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".